blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3679159

EP3679159 - DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  30.06.2023
Database last updated on 24.08.2024
FormerRequest for examination was made
Status updated on  12.06.2020
FormerThe international publication has been made
Status updated on  16.03.2019
Formerunknown
Status updated on  12.10.2018
Most recent event   Tooltip22.12.2023New entry: Reply to examination report 
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2020/29]
Inventor(s)01 / KLIJN, Christiaan, Nicolaas
1 DNA Way
South San Francisco, CA 94080-4990 / US
02 / MALEK, Shiva
1 DNA Way
South San Francisco, CA 94080-4990 / US
03 / YEN, Ivana
1 DNA Way
South San Francisco, CA 94080-4990 / US
 [2020/29]
Representative(s)Belkacemi, Doria
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2020/29]Ayad, Doria
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date18779886.307.09.2018
[2020/29]
WO2018US50056
Priority number, dateUS201762556277P08.09.2017         Original published format: US 201762556277 P
[2020/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019051296
Date:14.03.2019
Language:EN
[2019/11]
Type: A1 Application with search report 
No.:EP3679159
Date:15.07.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 14.03.2019 takes the place of the publication of the European patent application.
[2020/29]
Search report(s)International search report - published on:EP14.03.2019
ClassificationIPC:C12Q1/6886
[2020/29]
CPC:
C12Q1/6886 (EP,KR,US); A61K31/519 (US); A61K31/553 (US);
A61K45/06 (US); A61P35/00 (US); C12Q2600/106 (EP,KR,US);
C12Q2600/156 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/29]
TitleGerman:DIAGNOSE- UND THERAPIEVERFAHREN FÜR KREBS[2020/29]
English:DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER[2020/29]
French:MÉTHODES DIAGNOSTIQUES ET THÉRAPEUTIQUES DU CANCER[2020/29]
Entry into regional phase08.04.2020National basic fee paid 
08.04.2020Designation fee(s) paid 
08.04.2020Examination fee paid 
Examination procedure20.03.2020Amendment by applicant (claims and/or description)
08.04.2020Examination requested  [2020/29]
08.04.2020Date on which the examining division has become responsible
30.06.2023Despatch of a communication from the examining division (Time limit: M06)
21.12.2023Reply to a communication from the examining division
Fees paidRenewal fee
11.09.2020Renewal fee patent year 03
09.09.2021Renewal fee patent year 04
09.09.2022Renewal fee patent year 05
20.09.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO2013178581  (BAYER PHARMA AG [DE]);
 [X]US2015057275  (DIAS-SANTAGATA DORA [US], et al);
 [Y]US2015307947  (BASU GARGI [US], et al);
by applicantUS4656127
 US4683195
 US4943533
 WO9102087
 US4998617
 WO9215712
 US5212290
 EP0659439
 US5457105
 US5475001
 WO9630347
 WO9633978
 WO9633979
 WO9633980
 WO9640210
 US5616582
 US5654307
 US5679683
 WO9738983
 WO9814451
 US5747498
 US5760041
 US5770599
 US5804396
 WO9843960
 WO9850433
 WO9850038
 US5866572
 WO9906378
 WO9906396
 WO9909016
 US5891996
 WO9924037
 US6002008
 US6084095
 US6140332
 US6235883
 US6265410
 US6344459
 US6344455
 US6391874
 US6399602
 US6455534
 US6455249
 US6521620
 US6596726
 US6602863
 US6713484
 WO2005062795
 WO2007002325
 WO2007002433
 WO2007044515
 WO2008024725
 WO2008024724
 WO2008067481
 WO2008079903
 WO2008079906
 WO2008157179
 WO2009082687
 WO2009085983
 WO2009085980
 WO2010003025
 WO2010003022
 US2010249126
 WO2012118850
 WO2013020062
 WO2013100632
 WO2013130976
 WO2014036015
 WO2014060395
 WO2014151616
 WO2015032840
 WO2015075483
 WO2015085007
 WO2015103137
 WO2015103133
 WO2015154674
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.